Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jana Markova, Deniz Kahraman, Carsten Kobe, Magdalena Skopalova, Heidi Mocikova, Katerina Klaskova, Katerina Dedeckova, Hans-Theodor Eich, Boris Böll, Markus Dietlein & Tomas Kozak. (2012) Role of [18F]-fluoro-2-deoxy-d-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone. Leukemia & Lymphoma 53:1, pages 64-70.
Read now
Read now
Andrea Gallamini, Francesca Fiore, Roberto Sorasio & Michel Meignan. (2009) Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leukemia & Lymphoma 50:11, pages 1761-1764.
Read now
Read now
Michel Meignan, Emmanuel Itti, Andrea Gallamini & Corinne Haioun. (2009) Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation – where do we stand?. Leukemia & Lymphoma 50:11, pages 1753-1756.
Read now
Read now
Ginna G. Laport. (2008) Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review. Leukemia & Lymphoma 49:10, pages 1854-1859.
Read now
Read now
Articles from other publishers (24)
Richard T. HoppeRanjana H. AdvaniWeiyun Z. AiRichard F. AmbinderPhilippe ArmandCeleste M. BelloCecil M. BenitezPhilip J. BiermanKirsten M. BoughanBouthaina DabajaLeo I. GordonFrancisco J. Hernandez-IlizaliturriAlex F. HerreraEphraim P. HochbergJiayi HuangPatrick B. JohnstonMark S. KaminskiVaishalee P. KenkreNadia KhanRyan C. LynchKami MaddocksJonathan McConathyMatthew McKinneyMonika MetzgerDavid MorganCarolyn MulroneyRachel RabinovitchKaren C. RosenspireStuart SeropianRanda TaoJane N. WinterJoachim Yahalom, Jennifer L. BurnsNdiya Ogba. (2020) Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:6, pages 755-781.
Crossref
Crossref
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2020) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Crossref
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2019) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Yan Li, You Qin, Liduan Zheng & Hong Liu. (2017) Extranodal presentation of Hodgkin's lymphoma of the sternum: A case report and review of the literature. Oncology Letters.
Crossref
Crossref
Liang Wang, Jing-Hua Wang, Xi-Wen Bi, Xiao-Qin Chen, Yue Lu & Zhong-Jun Xia. (2017) Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients. Oncotarget 8:58, pages 99104-99111.
Crossref
Crossref
Colette Zwarthoed, Tarec Cristoffer El-Galaly, Maria Canepari, Matthieu John Ouvrier, Julien Viotti, Marc Ettaiche, Simonetta Viviani, Luigi Rigacci, Livio Trentin, Chiara Rusconi, Stefano Luminari, Maria Cantonetti, Silvia Bolis, Anna Borra, Jacques Darcourt, Flavia Salvi, Edyta Subocz, Joanna Tajer, Waldemar Kulikowski, Bogdan Malkowski, Jan Maciej Zaucha & Andrea Gallamini. (2017) Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. Journal of Nuclear Medicine 58:8, pages 1249-1254.
Crossref
Crossref
Naveen M. KulkarniDaniella F. PinhoSrikala NarayananAvinash R. KambadakoneJeremy S. AbramsonDushyant V. Sahani. (2017) Imaging for Oncologic Response Assessment in Lymphoma. American Journal of Roentgenology 208:1, pages 18-31.
Crossref
Crossref
Sree Harsha Tirumani, Ann S. LaCasce & Heather A. Jacene. (2015) Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma. PET Clinics 10:2, pages 207-225.
Crossref
Crossref
Paolo G. Gobbi, Andrés J.M. Ferreri, Maurilio Ponzoni & Alessandro Levis. (2013) Hodgkin lymphoma. Critical Reviews in Oncology/Hematology 85:2, pages 216-237.
Crossref
Crossref
Hamdy M. Zwam, Emad E. Habib & Mustafa E. AL-Daly. (2013) Involved Nodal Radiotherapy vs. Involved Field Radiotherapy after Chemotherapy in the Treatment of Early Stage Hodgkin’s Lymphoma. Journal of Cancer Therapy 04:01, pages 271-279.
Crossref
Crossref
Pier Luigi Zinzani, Luigi Rigacci, Vittorio Stefoni, Alessandro Broccoli, Benedetta Puccini, Antonio Castagnoli, Luca Vaggelli, Lucia Zanoni, Lisa Argnani, Michele Baccarani & Stefano Fanti. (2011) Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients. European Journal of Nuclear Medicine and Molecular Imaging 39:1, pages 4-12.
Crossref
Crossref
Nikolai Podoltsev, Jill Lacy & Julie Vose. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
3
39
.
R. Abgral, P.-Y. Le Roux, F. Blanc-Béguin, T. Eugène, S. Querellou, C. Bodet-Milin, F. Kraeber-Bodéré & P.-Y. Salaün. (2011) Évaluation de la réponse thérapeutique par tomographie par émission de positons (TEP) au 18fluoro-désoxyglucose (FDG) en oncologie-hématologie. Médecine Nucléaire 35:11, pages 600-607.
Crossref
Crossref
Stephan D. Voss. (2011) Pediatric oncology and the future of oncological imaging. Pediatric Radiology 41:S1, pages 172-185.
Crossref
Crossref
A. Julian, T. Wagner, P. Payoux, A. Hitzel & J.-P. Esquerré. (2011) Évaluation de la réponse au traitement des lymphomes : rôle de la TEP-FDG. Médecine Nucléaire 35:1, pages 21-28.
Crossref
Crossref
R.C. Delgado-Bolton & J.L. Carreras Delgado. (2011) Évaluation de la réponse au traitement du lymphome avec la TEP 18F-FDG : existe-t-il un consensus dans l’évaluation de la réponse ?. Médecine Nucléaire 35:1, pages 29-37.
Crossref
Crossref
Alberto Fabbri, Alessandro Gozzetti, Francesco Forconi & Francesco Lauria. (2010) Predicting the clinical course of Hodgkin lymphoma. Nature Reviews Clinical Oncology 7:8, pages 1-1.
Crossref
Crossref
Carmel G. CroninRonan SwordsMylene T. Truong, Chitra Viswanathan, Eric Rohren, Francis J. GilesMichael O'DwyerJohn F. Bruzzi. (2010) Clinical Utility of PET/CT in Lymphoma. American Journal of Roentgenology 194:1, pages W91-W103.
Crossref
Crossref
Samer A. Srour & Luis E. Fayad. 2010. Neoplastic Hematopathology. Neoplastic Hematopathology
367
389
.
Stephan D. Voss, Gregory H. Reaman, Sue C. Kaste & Thomas L. Slovis. (2009) The ALARA concept in pediatric oncology. Pediatric Radiology 39:11, pages 1142-1146.
Crossref
Crossref
Birgit BurkhardtAlfred ReiterEva LandmannPeter LangLisa LassayRoswitha DickerhoffMax LakomekGünter HenzeArend von Stackelberg. (2009) Poor Outcome for Children and Adolescents With Progressive Disease or Relapse of Lymphoblastic Lymphoma: A Report From the Berlin-Frankfurt-Muenster Group. Journal of Clinical Oncology 27:20, pages 3363-3369.
Crossref
Crossref
J. Markova, C. Kobe, M. Skopalova, K. Klaskova, K. Dedeckova, A. Plütschow, H.T. Eich, M. Dietlein, A. Engert & T. Kozak. (2009) FDG–PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value. Annals of Oncology 20:7, pages 1270-1274.
Crossref
Crossref
Azita Monazzam, Pasha Razifar, Susan Ide, Michael Rugaard Jensen, Raymond Josephsson, Carl Blomqvist, Bengt Langström & Mats Bergström. (2009) Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake. Nuclear Medicine and Biology 36:3, pages 335-342.
Crossref
Crossref
Carsten KobeMarkus DietleinJeremy FranklinJana MarkovaAndreas LohriHolger AmthauerSusanne KlutmannWolfram H. KnappJosee M. ZijlstraAndreas BockischMatthias WeckesserReinhard LorenzMathias SchreckenbergerRoland BaresHans T. Eich, Rolf-Peter Mueller, Michael Fuchs, Peter Borchmann, Harald SchichaVolker DiehlAndreas Engert. (2008) Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood 112:10, pages 3989-3994.
Crossref
Crossref